Anhui Huaheng Biotechnology Co. Ltd. A (688639.SS) stock: key figures, P/E, revenue and dividend

Health Care · Biotechnology · China · ISIN CNE1000052M6

Price
15.05 CNY
Market cap
3.79 bn CNY
P/E (2025)
28.59
P/S (2025)
1.32
Dividend yield
1.06 %
Net margin
4.63 %
Return on equity (ROE)
5.00 %
Return on assets (ROA)
2.29 %

Anhui Huaheng Biotechnology Co. Ltd. A financials

Fiscal year20242025
Revenue2.18 bn CNY2.86 bn CNY
Gross profit539.66 m CNY608.62 m CNY
Operating income199.32 m CNY129.65 m CNY
EBIT242.44 m CNY169.39 m CNY
Net income189.52 m CNY132.41 m CNY
Diluted EPS – continuing operations0.82 CNY0.53 CNY

Full history since 2012, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Anhui Huaheng Biotechnology Co. Ltd. A

Anhui Huaheng Biotechnology Co., Ltd. engages in the research and development, production, and sale of bio-based products through bio-manufacturing in China and internationally. The company offers amino acid products, including the alanine series, L-valine, isoleucine, tryptophan, and arginine; vitamin products, such as D-calcium pantothenate, D-panthenol, and inositol; bio-based new material monomers, including 1,3-propanediol and succinic acid; and other products, including malic acid and arbutin. Its products are used in daily chemical products, medicine, health and personal care products, cosmetic products, food additives, feeds, animal nutrition, plant nutrition, and functional food and nutrition. The company was formerly known as Anhui Huaheng Biological Engineering Co., Ltd. and changed its name to Anhui Huaheng Biotechnology Co., Ltd. in November 2013. The company was founded in 2005 and is based in Hefei, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.